Syed Ibrahim Bukhari: Transforming the Diagnosis of IBMFC through Genomic in LMICs
Syed Ibrahim Bukhari, Clinical Fellow at The Hospital for Sick Children, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Expert Review of Hematology, adding:
“Proud to share our recent publication in Expert Review of Hematology
Genetic insights and diagnostic challenges in inherited bone marrow failure syndromes: a comprehensive study from a low middle-income country
Inherited bone marrow failure syndromes (IBMFS) are rare, complex, and frequently misdiagnosed as idiopathic aplastic anemia—especially in resource-limited settings where access to advanced diagnostics remains challenging.
In our pediatric cohort, genomic testing proved transformative:
- 34% diagnostic yield with confirmed molecular diagnoses
- Several children had their original diagnosis revised after genetic testing
- Commonly affected genes included MPL, FANCA, and DNAJC21
- Findings directly impacted treatment decisions, donor selection for HSCT, and family counseling
- High rates of VUS highlighted the urgent need for better South Asian representation in global genomic databases
Why this matters:
For children with marrow failure, the correct diagnosis can mean the difference between immunosuppressive therapy, disease-specific treatment, or urgent transplant planning.
Our study reinforces that precision medicine should not be limited by geography.
Grateful to my co-authors, mentors, and all families who made this work possible.”
Title: Genetic insights and diagnostic challenges in inherited bone marrow failure syndromes: a comprehensive study from a low middle-income country
Authors: Syed Ibrahim Bukhari, Fizza Akbar, Salman Kirmani, Zehra Fadoo, Asim Fakhruddin Belgaumi, Sadaf Altaf
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 20:01Anand Gupta: Timing of DOAC Initiation in Newly Diagnosed Atrial Fibrillation
-
Sep 25, 2026, 19:56Steven Fein: A History of Blood Clots Doesn’t Mean a Healthy Pregnancy Is Out of Reach
-
Sep 25, 2026, 19:54Pedro Perez: “Provoked” VTE May Not Always Mean the Risk Disappears When the Provoking Event Does
-
Sep 25, 2026, 19:53Kemal Karaagac: Calcitriol May Reduce Thrombotic Risk in MASLD
-
Sep 25, 2026, 19:52The SINGLE-AF Trial Anticoagulation for Intermediate Stroke Risk – NEJM
-
Sep 25, 2026, 19:49Shinya Goto: DOAC vs Placebo in Intermediate Stroke Risk of AF in Single Country?
-
Sep 25, 2026, 19:47Bryan Cotton: DOACs Versus Nothing When Stroke Risk Is Not Zero
-
Sep 25, 2026, 19:45Selin Yaman Seval: ITP Is More Than a Low Platelet Count
-
Sep 25, 2026, 19:44Cy R. Wilkins: Treating Chemotherapy-Induced Thrombocytopenia Beyond the Platelet Count